Regulon

Regulon: R-2814

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
62.7901619Pr-38Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
2034 ENSG00000116016 EPAS1 Q99814
10253 ENSG00000136158 SPRY2 O43597
636 ENSG00000151746 BICD1 Q96G01
9529 ENSG00000166170 BAG5 A0A024R6M6
55584 ENSG00000174343 CHRNA9 Q9UGM1
25907 ENSG00000249992 TMEM158 Q8WZ71

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
BELZUTIFANEPAS1Small moleculeINHIBITOREndothelial PAS domain-containing protein 1 inhibitor40
NERAMEXANEGRIN1Small moleculeANTAGONISTNeuronal acetylcholine receptor; alpha9/alpha10 antagonist30
NERAMEXANE MESYLATEGRIN1Small moleculeANTAGONISTNeuronal acetylcholine receptor; alpha9/alpha10 antagonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2814

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-02519MMP3down-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-04711ADAMTS7up-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-05806SYNE2down-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-05967SIRPGdown-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-07389THOC2down-regulatesTNFRSF25repressesR-281422Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-17514CNTNAP3up-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-23320PABPC3up-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-23534CKMT1Adown-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE

CMF-29847ABCC9down-regulatesTNFRSF25repressesR-281421Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

BELZUTIFAN, NERAMEXANE, NERAMEXANE MESYLATE